Zhejiang HISUN Biomaterials Co. Ltd. A (688203) - Net Assets
Based on the latest financial reports, Zhejiang HISUN Biomaterials Co. Ltd. A (688203) has net assets worth CN¥1.48 Billion CNY (≈ $216.18 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.02 Billion ≈ $295.59 Million USD) and total liabilities (CN¥542.63 Million ≈ $79.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Zhejiang HISUN Biomaterials Co. Ltd. A liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.48 Billion |
| % of Total Assets | 73.14% |
| Annual Growth Rate | 24.6% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 51.65 |
Zhejiang HISUN Biomaterials Co. Ltd. A - Net Assets Trend (2020–2024)
This chart illustrates how Zhejiang HISUN Biomaterials Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Also explore Zhejiang HISUN Biomaterials Co. Ltd. A assets under control for the complete picture of this company's asset base.
Annual Net Assets for Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)
The table below shows the annual net assets of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024. For live valuation and market cap data, see Zhejiang HISUN Biomaterials Co. Ltd. A stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.49 Billion ≈ $218.26 Million |
+0.69% |
| 2023-12-31 | CN¥1.48 Billion ≈ $216.76 Million |
+2.02% |
| 2022-12-31 | CN¥1.45 Billion ≈ $212.46 Million |
+122.00% |
| 2021-12-31 | CN¥654.02 Million ≈ $95.70 Million |
+5.70% |
| 2020-12-31 | CN¥618.77 Million ≈ $90.55 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhejiang HISUN Biomaterials Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 12586981670.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥83.48 Million | 5.60% |
| Other Components | CN¥1.41 Billion | 94.40% |
| Total Equity | CN¥1.49 Billion | 100.00% |
Zhejiang HISUN Biomaterials Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Zhejiang HISUN Biomaterials Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tera Light Ltd
TA:TRLT
|
$403.47 Million |
|
Enjoyor
SHE:300020
|
$403.51 Million |
|
Chongqing New Dazheng Property Grp
SHE:002968
|
$403.63 Million |
|
Peijia Medical Limited
F:4WO
|
$403.65 Million |
|
Frp Holdings Ord
NASDAQ:FRPH
|
$403.34 Million |
|
Pitti Engineering Limited
NSE:PITTIENG
|
$403.34 Million |
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
$403.21 Million |
|
Cion Investment Corp
NYSE:CION
|
$403.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhejiang HISUN Biomaterials Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,481,265,073 to 1,491,555,628, a change of 10,290,555 (0.7%).
- Net income of 35,504,616 contributed positively to equity growth.
- Dividend payments of 23,589,255 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥35.50 Million | +2.38% |
| Dividends Paid | CN¥23.59 Million | -1.58% |
| Other Changes | CN¥-1.62 Million | -0.11% |
| Total Change | CN¥- | 0.69% |
Book Value vs Market Value Analysis
This analysis compares Zhejiang HISUN Biomaterials Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.85x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.34x to 1.85x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥4.07 | CN¥13.60 | x |
| 2021-12-31 | CN¥4.30 | CN¥13.60 | x |
| 2022-12-31 | CN¥7.16 | CN¥13.60 | x |
| 2023-12-31 | CN¥7.31 | CN¥13.60 | x |
| 2024-12-31 | CN¥7.36 | CN¥13.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhejiang HISUN Biomaterials Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.20%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.38x
- Recent ROE (2.38%) is below the historical average (3.77%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 4.90% | 11.57% | 0.22x | 1.90x | CN¥-31.56 Million |
| 2021 | 5.39% | 6.03% | 0.49x | 1.81x | CN¥-30.12 Million |
| 2022 | 3.24% | 7.77% | 0.31x | 1.33x | CN¥-98.15 Million |
| 2023 | 2.94% | 5.78% | 0.37x | 1.38x | CN¥-104.58 Million |
| 2024 | 2.38% | 4.20% | 0.41x | 1.38x | CN¥-113.65 Million |
Industry Comparison
This section compares Zhejiang HISUN Biomaterials Co. Ltd. A's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $2,769,045,563
- Average return on equity (ROE) among peers: 6.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhejiang HISUN Biomaterials Co. Ltd. A (688203) | CN¥1.48 Billion | 4.90% | 0.37x | $403.35 Million |
| North Huajin Chemical Industries Co Ltd (000059) | $1.37 Billion | 0.00% | 0.79x | $1.28 Billion |
| Sichuan Chemical Co Ltd (000155) | $1.46 Billion | 0.78% | 1.16x | $4.82 Billion |
| Jiangsu Wujiang China Eastern Silk Market Co Ltd (000301) | $506.50 Million | 16.41% | 1.45x | $12.92 Billion |
| Zangge Holding Co Ltd (000408) | $304.26 Million | 8.29% | 1.38x | $20.72 Billion |
| Sichuan Jinlu Group Co Ltd (000510) | $1.46 Billion | 0.89% | 0.57x | $1.47 Billion |
| Jilin Gpro Titanium Industry Co Ltd (000545) | $269.12 Million | 8.73% | 0.27x | $438.99 Million |
| Aoyuan Beauty Valley Technology Co Ltd (000615) | $728.86 Million | 0.46% | 0.67x | $855.32 Million |
| Ningxia Younglight Chemicals Co Ltd (000635) | $934.64 Million | 13.67% | 2.94x | $472.35 Million |
| Maoming Petro-Chemical Shihua Co Ltd (000637) | $1.03 Billion | 8.78% | 0.45x | $362.87 Million |
| Inner Mongolia Yuan Xing Energy Co Ltd (000683) | $19.62 Billion | 9.23% | 0.83x | $4.87 Billion |
About Zhejiang HISUN Biomaterials Co. Ltd. A
Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. The company's products are used in various applications that include 3D printing, extrusion, thermoforming, film and laminating, injection molding, non-woven fabric, and injection blow molding. Zhejiang Hisun Biomaterials Co.Ltd. was founded in 2004 and is based in Taizhou, … Read more